Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy

被引：0
作者：
Philip J. Saylor
Nancy L. Keating
Matthew R. Smith
机构：
[1] Massachusetts General Hospital Cancer Center,Division of Hematology
[2] Harvard Medical School,Oncology
来源：
Journal of General Internal Medicine | 2009年 / 24卷
关键词：
prostate cancer; survivorship; GnRH agonists; osteoporosis; bisphosphonates; diabetes; obesity; cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 394
页数：5
相关论文
共 50 条
  • [1] Prostate Cancer Survivorship: Prevention and Treatment of the Adverse Effects of Androgen Deprivation Therapy
    Saylor, Philip J.
    Keating, Nancy L.
    Smith, Matthew R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 389 - 394
  • [2] Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer
    Saylor, Philip J.
    Smith, Matthew R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2010, 8 (02): : 211 - 223
  • [3] Adverse effects of androgen-deprivation therapy in prostate cancer and their management
    Rhee, Handoo
    Gunter, Jennifer H.
    Heathcote, Peter
    Ho, Ken
    Stricker, Phillip
    Corcoran, Niall M.
    Nelson, Colleen C.
    BJU INTERNATIONAL, 2015, 115 : 3 - 13
  • [4] Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications
    Tzortzis, Vasileios
    Samarinas, Michael
    Zachos, Ioannis
    Oeconomou, Athanasios
    Pisters, Louis L.
    Bargiota, Alexandra
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2017, 16 (02): : 115 - 123
  • [5] Review of Major Adverse Effects of Androgen-deprivation Therapy in Men With Prostate Cancer
    Taylor, Lockwood G.
    Canfield, Steven E.
    Du, Xianglin L.
    CANCER, 2009, 115 (11) : 2388 - 2399
  • [6] Adverse Effects of Androgen Deprivation in Elderly Men with Prostate Cancer
    Zarzour, Ahmad
    Shevach, Jeffrey W.
    Morgans, Alicia K.
    CURRENT GERIATRICS REPORTS, 2019, 8 (04) : 315 - 321
  • [7] Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
    Chi, Jen-Tsan
    Lin, Pao-Hwa
    Tolstikov, Vladimir
    Oyekunle, Taofik
    Chen, Emily Y.
    Bussberg, Valerie
    Greenwood, Bennett
    Sarangarajan, Rangaprasad
    Narain, Niven R.
    Kiebish, Michael A.
    Freedland, Stephen J.
    CANCER MEDICINE, 2020, 9 (11): : 3691 - 3702
  • [8] Adverse effects of androgen deprivation therapy in men with prostate cancer: a focus on metabolic and cardiovascular complications
    Collins, Lauren
    Basaria, Shehzad
    ASIAN JOURNAL OF ANDROLOGY, 2012, 14 (02) : 222 - 225
  • [9] Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications
    Vasileios Tzortzis
    Michael Samarinas
    Ioannis Zachos
    Athanasios Oeconomou
    Louis L. Pisters
    Alexandra Bargiota
    Hormones, 2017, 16 : 115 - 123
  • [10] Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review
    Edmunds, Kim
    Tuffaha, Haitham
    Galvao, Daniel A.
    Scuffham, Paul
    Newton, Robert U.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2079 - 2093
12345